Acadia Pharmaceuticals, Inc. Community Page | What other sites are saying about Acadia Pharmaceuticals, Inc.

Acadia Pharmaceuticals, Inc.

(NQ: ACAD)

13.68 USD -0.47 (-3.32%)

Streaming Delayed Price / Updated: 11:31 AM EDT, May 21, 2013 / Add to My Watchlist

(ACAD) Community Analysis from

READ MORE (ACAD)

Bulls REASONS TO BUY

View all Bulls Reasons

Bears REASONS TO SELL

View all Bears Reasons

May 21, 2013

ACAD

(Samurai Trader, 4/11/13)

ACAD has been on the relative strength list for months, but thanks to the scale of the chart, looks like it hasn't done much since last November. That is very misleading: this actually had a range where the op was more...(read more)

After Hours Stock Movers on January 14th

(Wall St. Cheat Sheet, 1/14/11)

See why these stocks are moving the markets after-hours and will be widely watched at tomorrow's opening bell ...

(ACAD) Acadia Pharmaceuticals Gets Pimavanserin Back

(Stock Blog Hub, 10/28/10)

This morning, Acadia Pharmaceuticals (ACAD) announced that it has entered into an agreement with Biovail Labs (BLS), a wholly owned subsidiary of Valeant Pharmaceuticals...(read more)

View all posts about ACADIA Pharmaceuticals (ACAD)

ACADIA Pharmaceuticals (ACAD) Company Overview

There is no analysis for ACAD yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates